Literature DB >> 10759865

The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor.

M Kontou1, D D Leonidas, E H Vatzaki, P Tsantili, A Mamalaki, N G Oikonomakos, K R Acharya, S J Tzartos.   

Abstract

The crystal structure of the Fab fragment of a rat monoclonal antibody, number 192, with a very high affinity (Kd = 0.05 nM) for the main immunogenic region of the human muscle acetylcholine receptor (AChR), has been determined and refined to 2.4 A resolution by X-ray crystallographic methods. The overall structure is similar to a Fab (NC6.8) from a murine antibody, used as a search model in molecular replacement. Structural comparisons with known antibody structures showed that the conformations of the hypervariable regions H1, H2, L1, L2, L3 of Fab192 adopt the canonical structures 1, 1, 2, 1, and 1, respectively. The surface of the antigen-binding site is relatively planar, as expected for an antibody against a large protein antigen, with an accessible area of 2865 A2. Analysis of the electrostatic surface potential of the antigen-binding site shows that the bottom of the cleft formed in the center of the site appears to be negatively charged. The structure will be useful in the rational design of very high affinity humanized mutants of Fab192, appropriate for therapeutic approaches of the model autoimmune disease myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759865     DOI: 10.1046/j.1432-1327.2000.01252.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.

Authors:  Jie Luo; Palmer Taylor; Mario Losen; Marc H de Baets; G Diane Shelton; Jon Lindstrom
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

2.  Myasthenogenicity of the main immunogenic region.

Authors:  Jon Lindstrom; Jie Luo
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

3.  Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains.

Authors:  Jon Lindstrom; Jie Luo; Alexander Kuryatov
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

4.  Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications.

Authors:  Kaori Noridomi; Go Watanabe; Melissa N Hansen; Gye Won Han; Lin Chen
Journal:  Elife       Date:  2017-04-25       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.